Watch our exclusive interview, recorded live at the AHA Scientific Sessions 2022 conference, with three investigators from the BEST-CLI trial. 

The scans can be completed in less than five seconds and require less radiation than a traditional chest x-ray.  

Cian McCarthy, MD, Massachusetts General Hospital, and a member of the National Cardiovascular Data Registry (NCDR) Chest Pain-MI registry steering committee, explains a study of the NCDR data showing only 33% of hospitals are using high-sensitivity troponin.

But how reliable can synthetic radiologic images be in research settings? Are they as good as the real thing? 

Jason Andrade, MD, director of electrophysiology, Vancouver General Hospital, and principal investigator of the PROGRESSIVE AF trial, explains how cryoablation can be used as a frontline treatment for atrial fibrillation (AFib) before drugs in this AHA late-breaker. 

PET/CT with the common radiotracer 18F-FDG has been found useful for workups and monitoring of infections in real-world hospitalized patients, according to a study conducted by researchers at Yale and Stanford published Nov. 14. 

Contradicting prior research connecting heavy ordering of diagnostic exams with fear of malpractice charges—aka “defensive medicine”—a new survey shows ED referrers more focused on not harming patients than on not getting sued.

The American Heart Association 2022 Scientific Sessions included 35 late-breaking studies and 39 featured science sessions presented at the meeting in Chicago, Nov. 5-7. Here is the list of all these studies with links to more information on the data.